SPONSORED | Crafted in the Cape winelands, this golden elixir is nothing less than exceptional: it presents a depth and complexity of flavour like no other
Alembic Pharmaceuticals plans to launch 20 new products in the US market in FY24, including oncology and non-oncology injectables, derma, and ophthalmic products. The launches will be facilitated by the newly USFDA-compliant facilities. The company also plans to take advantage of drug shortages in the US.
The Vadodara-based company said consolidated profit rose to 1.21 billion rupees ($14.6 million) for the quarter ended June 30 from a loss of 658.8 million rupees a year earlier.
Stocks in focus today: Indian stock market could remain subdued given the gloomy global environment. Stock-specific action is likely to continue in the market with the ongoing result season. Bharti Airtel, Sun Pharma, Titan Company, Adani Wilmar, IndiGo, Zomato among stocks in news on Thursday, August 3, 2023.